•  Dubai Investments acquires a 34.3 percent equity stake in Global Fertility Partners (GFP), a leading network of fertility and reproductive genetics centers in the Middle East.

•  GFP secures approximately US$60 million in equity financing, enabling the expansion of its fertility and women’s health centers across the MENA region, to become the top fertility network globally and adhere to international best practices.

•  Dubai Investments’ strategic investment in GFP, its fourth in the healthcare sector, aligns with the company’s diversification strategy. The partnership aims to support GFP’s ambitious growth plans, leveraging synergies and contributing to the future of healthcare investments.

Dubai Investments has acquired a 34.3 per cent equity stake in Global Fertility Partners (GFP), a prominent network of fertility and reproductive genetics centers in the Middle East, according to media reports.

GFP has secured approximately US$60 million in equity financing, empowering its expansion across the MENA region. 

The objective is to establish the leading fertility network in the region, ranking among the top 10 globally, with a commitment to global best practices and a pursuit of international excellence.

Khalid Bin Kalban, Vice Chairman and CEO of Dubai Investments, highlighted the significance of this equity investment, marking the company’s fourth strategic move in the healthcare sector as part of its ongoing diversification strategy. 

The partnership aims to support GFP’s ambitious growth plans by leveraging synergies and reinforcing Dubai Investments’ dedication to shaping the future of healthcare investments.

Majd Abu Zant, GFP Founder and CEO, expressed the commitment to setting new standards in fertility and women’s health through research, innovation, and patient-centric approaches. The funding will expedite GFP’s growth, allowing them to establish a robust foundation for continuous expansion.

Initially focusing on Saudi Arabia, the network aims to provide numerous benefits for patients, including faster introduction of new technologies, superior clinical outcomes, and reduced treatment costs. GFP’s flagship facility in Riyadh, set to commence operations later this year, will elevate standards in fertility care and reproductive genetics, establishing a new benchmark for the region.

With the secured funding, GFP plans to build fertility and women’s health centers along with a network of satellite clinics in Saudi Arabia and the UAE. Construction is expected to begin in the coming months, and GFP has identified potential acquisition targets to accelerate regional platform growth.